Amid Safety Concerns, Weight Loss Drug Qsymia Probably Won’t Get Approval In The EU

A

admin

Administrator
Joined
Jun 17, 2007
Messages
66,217
Reaction score
0
Points
36
Age
50
Location
Canada
Earlier this week, a weight loss drug called Qsymia hit the market in the US. It was the first new FDA-approved anti-obesity medication to be introduced in over a decade. But Britons who are looking to lose weight may not be able to get their hands on it in the near future--or ever. According to the drug's parent company, VIVUS, it's unlikely that the very-strict European regulatory committee will approve the drug, which is raising questions about Qsymia's purported safety. More »Post from: Blisstree
 
Back
Top